Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 — Minneapolis, Minnesota

Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 has participated in 1 clinical trials.

Therapeutic areas: Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Sponsors: EMD Serono Research & Development Institute, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200?

Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 conducted?

Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 has 1 clinical trials on record. Their work covers Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer Third Line.

Is Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 accredited by Crixeo Health?

Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, P.A. 910 East 26th Street, Suites 100 and 200?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.